Skip to main content
OpenTrials

Clinical trial condition

Primary Central Nervous System Lymphoma

Explore clinical trials studying Primary Central Nervous System Lymphoma. Study availability and eligibility vary by location and protocol.

38 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Primary Central Nervous System Lymphoma trial results

Recruiting

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

NCT07082868

Conditions
Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma (PCNSL), +4 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL

NCT07350850

Conditions
PCNSL, Primary Central Nervous System Lymphoma
Locations
  • The First Affiliated Hospital of Fujian Medical University Xiamen, Fujian, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • China-Japan Union Hospital of Jilin University Changchun, Jilin, China
  • Shanxi Provincial People's Hospital Taiyuan, Shanxi, China
View Trial Details
Recruiting

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

NCT04421560

Conditions
Disease Attributes, Neoplasms, Pathologic Processes, +6 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

NCT06175000

Conditions
Primary Central Nervous System Lymphoma
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Providence Health & Services; Providence Neurological Specialties Portland, Oregon, United States
  • Pennsylvania State University Hershey, Pennsylvania, United States
View Trial Details

Related conditions